Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3002278 | Nutrition, Metabolism and Cardiovascular Diseases | 2013 | 7 Pages |
Abstract
The enthusiastic reports of the nonhematopoietic cytoprotective potential of EPO and its derivatives in the cardiovascular system have not yet been confirmed in placebo-controlled clinical trials.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
W. Jelkmann, S. Elliott,